Executive Summary

The principal activity of Oxeco is the growth and development of businesses in the technology and science sectors and especially those which are complementary to the Company’s existing X-ray crystallography business. The process of growth and development will include investing, or acquiring assets, businesses or companies in these sectors. Acquisitions and investments may be funded with a combination of equity and cash, although the Oxeco may also utilise debt under certain conditions. It is anticipated that any further acquisitions, other than pure intellectual property transactions, will be structured through limited liability vehicles.

Oxeco acquired Oxray Limited in June 2007. Oxray was established in August 2006 with the objective of becoming a provider of molecular structure determination services to both industry and academic institutions. This is to be achieved by developing novel molecular structure determination software in house as well as in-licensing IP and potentially also making acquisitions in this field. Determining or verifying the molecular structure of a compound is a fundamental research activity that underpins some of the most commercially important areas of science being drug discovery, synthetic chemistry and materials science. Oxray’s initial focus is a structure determination technique known as X-ray crystallography.

Company History

 

  • Oxeco was established in October 2006 and was admitted to AIM in December 2006.
  • On 29 June 2007, the Group acquired the entire issued share capital of Oxray Ltd.

Current Events

 

Business Model

 

Products/Services

 

Segments/Customers

 

Production/Operations

 

Distribution/Routes to Market

 

Market & Competition

 

Market Share

 

Main Competitors

 

Competitive Strengths and Weaknesses

 

Management

 The Directors comprise Jussi Westergren, Michael Bretherton, Professor Stephen Davies, David Norwood and Professor Graham Richards.

Financials

 

Historicals

 

Current Trading

 

Forecast Drivers and Issues

 

Balance sheet

 

Cashflow

 

Valuation

 

Comparable Companies

 

SWOT Analysis

 

Strengths

 

Weaknesses

 

Opportunities

 

Threats

 

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here